Sareum Holdings plc (LON:SAR – Get Free Report) shares passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 29.92 ($0.38) and traded as low as GBX 26.56 ($0.33). Sareum shares last traded at GBX 26.65 ($0.33), with a volume of 25,737 shares trading hands.
Sareum Stock Performance
The stock has a fifty day simple moving average of GBX 26.19 and a 200 day simple moving average of GBX 29.92. The firm has a market cap of £28.77 million, a P/E ratio of -444.17 and a beta of -1.08.
About Sareum
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.
Further Reading
- Five stocks we like better than Sareum
- Insider Trades May Not Tell You What You Think
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Using the MarketBeat Stock Split Calculator
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.
